Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Medical Marijuana with Opioids in Hospice Patients
NCT03233633Phase 1Completed
- Sponsor
- The Connecticut Hospice
- Start
- May 2017
- Primary completion
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of cannabis in pain, sponsored by The Connecticut Hospice. Primary endpoints: Primary Reduction of Pain at 3 days and Reduction in Overall Opioid Utilization at 3 days. Started May 2017; status: completed.
02
Drugs
cannabis
03
Conditions
pain
Beyond the preview
Go deeper on NCT03233633.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03233633.